Abstract
INTRODUCTION
Patients with a functional single ventricle due to double inlet left ventricle (DILV) and tricuspid atresia with transposed great arteries (TA-TGA) share several morphologic characteristics-both have a functional single ventricle (FSV) of left ventricular morphology with unrestricted pulmonary blood flow and a systemic outflow that passes through a bulboventricular foramen (BVF) to an outflow chamber before entering the aorta. Aortic coarctation and arch hypoplasia are common associations. Intracardiac obstruction of the systemic outflow tract obstruction (SOTO) may be present at birth or develop over time. These features are well recognized and a range of surgical approaches are employed including initial pulmonary artery banding and subsequent creation of a Damus-Kaye-Stansel connection either anticipating or treating SOTO. Alternatively, an initial Norwood approach may be used, addressing SOTO at the neonatal stage. BVF resection to manage SOTO, with its attendant risks of heart block and ventricular dysfunction, are rarely utilized as primary management. What constitutes an 'adequate' size of BVF and propensity to †The first two authors contributed equally to this work. further narrowing remains a focus of investigation [1, 2] . A palliative switch may also be utilized [3] .
For this patient group, the literature demonstrates significant pre-Fontan [4] and post-Fontan [5] attrition and differences between DILV and TA-TGA that are difficult to explain. Long-term outcomes, in particular ventricular performance, may be improved by optimizing the timing and choice of procedures in early childhood. We sought to define both pre-and post-Fontan outcomes in this group utilizing a population-based bi-national registry, evaluating the role of morphologic variables and choice of initial surgical management. We hypothesized that previously reported worse outcomes for TA-TGA versus DILV relate mostly to perioperative events and are a marker of morphologic complexity and that once effectively managed to Fontan, there would be no long-term difference in survival.
MATERIALS AND METHODS
Patients were identified from departmental databases at The Children's Hospital at Westmead (CHW), Sydney and Royal Children's Hospital (RCH), Melbourne. Patients were identified using the primary diagnosis on the initial echocardiogram, including all patients with DILV (with l-transposed great arteries) and TA-TGA. Patients with Holmes Heart (DILV with normally related great arteries) were excluded. Patients born after 2008 were excluded, with the expectation that all patients suitable for Fontan completion would have achieved this by the time of the study. Patients were identified at CHW from 1976 and RCH from 1969.
The study was approved by local Ethics Review, CHW (LNR/ 15/SCHN/42) and RCH (34086A). Subjects were also identified in the Australia and New Zealand Fontan Registry (www.fontanregis try.com) and records cross-checked with institutional information to ensure completeness and accuracy. The project was covered by Registry ethics approval (LNR/12/SCHN/455) and approved by the steering committee.
Statistical analysis
Patient baseline characteristics were summarized using mean, standard deviation, median, minimum and maximum for continuous variables and counts and percentages for categorical variables. Overall survival was defined as the period between date of birth and date of death. Patients who were alive were censored at the date they were last known alive, determined by date of last follow-up. The Kaplan-Meier method was used for all of the time to event analyses and the log-rank test was used to compare the time-to-events. Median follow-up time was estimated using the reverse Kaplan-Meier method. Cox proportional hazard models were used to test the association between potential predictors and overall survival. All potential predictors entered into the univariable analysis were selected on clinical grounds. The multivariable model was formulated by selecting variables that were significant at the 20% level in the univariable analysis. Then backward elimination was used until a model containing only variables whose Wald P-value was less than 0.05.
The proportional hazards assumption was assessed based on the method of Harrell-Lee and via diagnostic plots. All statistical analyses were performed in R (Version 3.1.2, http://www.r-pro ject.org/).
RESULTS
Patient characteristics and details of surgical procedures are summarized in Table 1 . Median age at first palliation was 26.5 days for the entire cohort, 26 days in the DILV group and 29 days in the TA-TGA group. SOTO at birth was present in 5% of the DILV cohort and 11% of the TA-TGA cohort, and developed over time in 44% of the DILV group and 27% of the TA-TGA group. Additional morphologies to the DILV and TA-TGA diagnoses included subpulmonary stenosis (25%), pulmonary atresia (9%), coarctation of the aorta (26%), interrupted aortic arch (6%) and valve abnormalities (15%). Completion of Fontan was achieved in 83% of the cohort (91% DILV group and 62% TA-TGA group). Thirty-four patients died (16%), 65% of which were related to known cardiopulmonary problems, 9% were sudden or unexpected deaths in patients doing well and 26% were unknown causes (Table 2 ). Median follow-up, defined as last followup appointment, was 17 years (range from 4 days to 49.8 years). No patient in the cohort underwent a palliative switch or Fontan takedown. The completeness of follow-up was 95%. Overall survival is shown in Figs 1 and 2. Survival for the DILV group was superior to those with TA-TGA (P < 0.001), with the majority of the difference being within the first 4 years of life. Five-year survival was 94% in the DILV group compared to 78% in the TA-TGA group. Overall survival estimates for the two groups are shown in the table within Fig. 2 .
Univariable Cox proportional hazards models are provided in Table 3 , highlighting a diagnosis of TA-TGA and the presence of SOTO at birth as significant predictors of worse survival (P < 0.01). There was no apparent impact of era in which the child was initially managed on survival, noting that the follow-up times are different between the eras. In a subanalysis where deaths after 3 years were censored, there was no difference in mortality according to era. By multivariate Cox regression analysis (Table 4) , TA-TGA was associated with reduced survival compared to DILV, HR (hazard ratio) 3.1 (1.6-6.1) P = 0.001. Presence of SOTO at birth was an important predictor of outcome, HR 3.5 (1.4 -9.2) P = 0.01. The proportional hazards assumption was satisfactory in all Cox regression analyses.
Survival following Fontan completion is shown in Fig. 3 , with no difference evident between morphologic subgroups following Fontan (log rank P = 0.9), Fig. 4 .
DISCUSSION
The management of patients with a functional single ventricle has evolved considerably over recent decades. Our focus on patients with DILV and TA-TGA relates to ongoing concern regarding short and long-term outcomes in this group, as well as uncertainty regarding optimal treatment pathways to Fontan.
We and others have reported early and mid-term surgical mortality associated with various initial strategies in single institution series [1, 3, 4, [6] [7] [8] [9] . In a comprehensive study of 140 patients treated between 1983 and 2002, Lan and colleagues [4] noted an overall survival of 83%, 80%, 75% and 52% at 5, 10, 15 and 25 years with a significantly worse outcome for TA-TGA patients thought to be related to perioperative deaths associated with neonatal Damus-Kaye-Stansel (DKS) procedures. The longerterm outcome for DILV and TA-TGA patients with a Fontan was not established in that series of patients, with a median age of 11.8 years and median follow-up of 7.7 years. Earing and colleagues [5] documented post-Fontan outcomes in 225 DILV patients managed from 1974 to 2001. Pre-Fontan mortality was not reported. Operative mortality was 9.3% with overall late survival of 78%. Twenty-five percent required BVF resection for SOTO at the time of Fontan, possibly reflecting management strategies from an earlier era. Late follow-up was available for 203 survivors with a median duration of 12 years. Actuarial survival of patients surviving the Fontan was 91%, 80%, 73% and 69% at 5,10, 15 and 20 years respectively, with sudden cardiac death being the most common cause of late mortality.
In this study, we demonstrated that TA-TGA was associated with a worse outcome than DILV, with overall survival being significantly lower compared to the DILV group (P = 0.001, Fig. 2 ). There was no excess of aortic arch obstruction, SOTO or other morphologic correlation to explain the difference observed. The majority of the deaths in the TA-TGA group were periprocedural and within the first 4 years of life. It is unclear why the TA-TGA group appeared to have an excess of perioperative mortality compared to the DILV group. After Fontan completion, there was no apparent difference between the outcome for DILV and TA-TGA.
We demonstrated that the presence of SOTO at birth was the only discriminating factor on multivariate analysis that was associated with a higher risk of death, HR 3.7. We were unable to demonstrate a difference between surgical strategies although the number of primary Norwood approaches was low compared to pathways utilizing pulmonary artery (PA) bands. There was a trend toward more patients with TA-TGA having SOTO at birth. These data raise the question of how outcomes may be different if contemporary approaches to Norwood surgery, known to be associated with less mortality, were applied to the cohort with SOTO present at birth. At CHW and RCH, current survival for non-HLH Norwood surgery demonstrates 75% alive at 1 year (between July 2011 and December 2014). Longer term outcomes may approximate those described by Wilder et al. [10] , for patients undergoing single ventricle management for hypoplastic left heart and similar pathologies.
Since multiple surgical pathways exist for the management of DILV and TA-TGA patients, we sought markers of outcome that could guide surgical management rather than universal application of a particular pathway [6-9, 11, 12] . Avoidance of major neonatal surgery, particularly from a neuro-developmental perspective [13] , remains a logical goal where this does not diminish growth velocity, compromise safety or adversely affect long term outcomes. For patients with DILV or TA-TGA and important aortic arch hypoplasia, a Norwood strategy would be followed. Patients with aortic coarctation but without transverse arch hypoplasia may be managed by repair of coarctation and pulmonary artery banding with good outcomes, deferring DKS connection to the second stage. Whilst pulmonary artery banding has been promoted as deleterious for the FSV, early progression to second stage before the development of significant ventricular hypertrophy and possible progression of SOTO due to narrowing of the BVF, has been associated with good outcomes [6, 12, 14] .
The question remains open as to whether a Norwood procedure with its attendant early risks provides a superior long term outcome in the absence of SOTO [15] and we were not able to address this in our study. When SOTO is present at birth, these outcomes suggest there should be a low threshold for performing a Norwood operation, since only the Norwood procedure adequately deals with this by creation of a neonatal DKS connection. A DKS should always be performed at Stage 2 given the high proportion of cases who ultimately develop SOTO (38%) and the significant risks of addressing this at the Fontan or after the Fontan.
A strength of our study is its population basis. The patients in our series were sourced from 2 centres serving a population of almost 14 million people with entry to the series at birth and allowing all patients to achieve Fontan by the age of 6 years. Data were also extracted from the Fontan Registry, which collects information on patients having undergone a Fontan in Australia and New Zealand with a combined population of 26 million people with more than 1200 patients followed.
Both pre-and post-Fontan outcomes in our series are superior to benchmarks in the literature [4, 5] with long term outcomes to beyond 30 years, making this the first report to comprehensively define pre-and post-Fontan outcomes in this patient group. Outcomes are expected to improve over time and our series shows that patients with DILV or TA-TGA who achieve Fontan have equivalent survival to the overall Fontan population [16] . These findings are substantially improved from previous reports [4, 5] and these outcome data should update information provided at the time of ante-natal counselling. Tham et al. [15] studied foetuses with DILV and demonstrated a 76% 10 year survival in those live-born, compared to 93% in our cohort at 10 years and 86% at 25 years.
Limitations
As a series spanning 3 decades, the patient cohort is not representative of current practice. For example, time to Stage 2 in the series was 27 months, whereas current expectations would have this occurring between 4 and 12 months depending on the initial operation. The number of initial Norwood procedures compared to PA band procedures was small and allocation to these groups may not have been done according to current criteria. Analysis included patients with subpulmonary stenosis who may not be truly representative of the physiology implied by a diagnosis of DILV and TA-TGA. Criteria for defining SOTO, BVF adequacy, arch hypoplasia and coarctation on echocardiography were not retrospectively defined, may be different at the 2 institutions and may not represent current approaches. As the series spanned 3 decades, data available in historic reports was limited and restricted further definition of these morphologic characteristics. Contemporary FSV management may ameliorate the differences in outcome between study groups. Reporting of retrospective outcomes to inform future practice should include outcomes from birth and/or foetal diagnosis and should take into consideration the impact of surgical procedures and medical conditions that affect long-term quality of life and quality of the Fontan circulation. The impact of current 'optimal' strategies on postFontan outcomes will only be known to the next generation, with survival only one of many important end-points.
CONCLUSIONS
Outcomes for TA-TGA were inferior to DILV but appear mostly related to periprocedural events, with equivalent survival after Fontan. The presence of SOTO at birth is highly predictive of mortality. Long-term outcomes for DILV are good and approximate outcomes for the wider Fontan population and these improved outcome data should inform antenatal counselling. 
